Hillan Kenneth J. (CIK 0001600359)

Latest company ownership

MEHCQ - Chrome Holding Co.

Role: Chief Therapeutics Officer

Shares held

221,876

Last filed at

Jun 7, 2023

Confidence Score

50.0

2025Q4

Confidence Score History

2022Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jun 5, 2023	Jun 7, 2023	Chrome Holding Co.	Chief Therapeutics Officer	Sell	91.3	+29,034	15.06%	✗	$31.9K
May 20, 2023	May 23, 2023	Chrome Holding Co.	Chief Therapeutics Officer	Sell	27.5	-4,628	-2.34%	✗	$9K
Feb 20, 2023	Feb 22, 2023	Chrome Holding Co.	Chief Therapeutics Officer	Sell	26.3	-5,457	-2.77%	✗	$15.7K
Nov 20, 2022	Nov 22, 2022	Chrome Holding Co.	Chief Therapeutics Officer	Sell	26.3	-4,628	-2.29%	✗	$13.8K
Aug 24, 2022	Aug 25, 2022	Chrome Holding Co.	Chief Therapeutics Officer	Sell	26.3	-8,753	-4.27%	✗	$31.9K
Aug 20, 2022	Aug 22, 2022	Chrome Holding Co.	Chief Therapeutics Officer	Sell	26.3	-4,628	-2.21%	✗	$15.4K
Jun 1, 2022	Jun 2, 2022	Chrome Holding Co.	Chief Therapeutics Officer	Sell	26.3	-4,627	-2.16%	✗	$13K